Bicara reaches substantial enrollment in HPV-negative head and neck cancer trialNov 9Quarterly updateArriVent BioPharma, Inc.Bicara Therapeutics
Merck collaborator posts pancreatic cancer results; new MK-1045, COPD trial records surfaceNov 6Weekly roundup, 14 itemsDaiichi SankyoensifentrineUpdated
IDEAYA completes darovasertib NDA, halts Phase 3 OptimUM-010 for enrollment issuesNov 3Quarterly updateAlector, Inc.Allogene Therapeutics
BeOne Medicines adds Phase 1 trial of BG-92505, a KEAP1 activator, in solid tumorsOct 29Weekly roundup, 3 itemsBeiGenebevacizumabUpdated
Phase 1b indibulin-capecitabine trial ended early after no dose-limiting toxicity seenSep 30Trial updateAlaunos Therapeutics, Inc.capecitabine
Results post for old USC gastric cancer trial; Bristol Myers Squibb opens new Zeposia PML studyJul 30Weekly roundup, 3 itemsBristol Myers Squibbiberdomide